SURFACE ONCOLOGY INC - COM (SURF)

CUSIP: 86877M209

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
24,671,179
Share change
+129,138
Total reported value
$117,984,981
Put/Call ratio
122%
Price per share
$4.78
Number of holders
101
Value change
-$532,761
Number of buys
47
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP 86877M209?
CUSIP 86877M209 identifies SURF - SURFACE ONCOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SURFACE ONCOLOGY INC - COM (SURF) as of Q4 2021

As of 31 Dec 2021, SURFACE ONCOLOGY INC - COM (SURF) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,671,179 shares. The largest 10 holders included ARK Investment Management LLC, Atlas Venture Associates IX, LLC, BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 101 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.